http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201916875-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d2fdd3b50079b2a618b2785106c24d1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 |
| filingDate | 2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d022516e3a023f57d0132f89371d761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f6b84940e48b370861dbcc74125a3ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c236a0ca541c0b022412a9f9d508fe8c |
| publicationDate | 2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201916875-A |
| titleOfInvention | Nano-sized emulsion immunocarrier for nasal mucosa and preparation method thereof |
| abstract | The present invention provides a nano-sized emulsion immunocarrier and a preparation method thereof, which are composed of the following components: a continuous aqueous phase containing H 2 O molecules; an oil phase substance containing fats; and An emulsification system of one of a continuous aqueous phase and an oil phase interface, and the emulsification system is an emulsifier mixture, the immunocarrier is characterized in that the emulsification system does not contain an ionic emulsifier, and the particle size of the emulsion is between 20 Nano to 200 nm. Through the nano-sized emulsion immunocarrier, it can effectively avoid the toxicity and possible harm of the ionic emulsifier to human cells, and provide a vaccine preparation capable of inducing a high immune response. |
| priorityDate | 2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 161.